Clinical Trial Update: GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GM-CSF mouthwash to prevent and treat mucositis in patients undergoing radiation therapy for head and neck cancer; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Mucositis
• Radiation Toxicity
• Tongue Cancer

Drugs mentioned

• GM-CSF mouthwash (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Marilyn Dodd | Conditions: Head and Neck Cancer, Mucositis Oral | Phase 3 | Status: COMPLETED | Results posted: 2013-05-16